Japanese company developing and manufacturing peptide and oligonucleotide active pharmaceutical ingredients for drug developers.
Founded in 2017 and based in Japan, PeptiStar Inc. develops and manufactures peptide and oligonucleotide active pharmaceutical ingredients for pharmaceutical and biotech companies, with services in analytics and clinical trial support. Its focus includes oncology and genetic therapies. The company has raised JPY 2,600.00 mn in total, most recently on April 17, 2025, from Sekisui Chemical, Shionogi Pharmaceutical, Sumitomo Chemical and TOAGOSEI. It reported revenue of JPY 1,416,995.20 in 2020.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in